克罗恩病患者肠道准备质量评估量表的性能表现
本研究评估了波士顿肠道准备量表、改良波士顿肠道准备量表、哈雷菲尔德清洁量表、美国食品药品监督管理局肠道清洁评估量表(BCAS)及100毫米视觉模拟量表在40例克罗恩病患者50段视频中的性能。除FDA BCAS在进镜时的评定者间信度ICC≥0.41外,其余量表信度均达ICC≥0.61,效度相关系数超过0.58,结肠肠道准备质量与内镜疾病活动度评分呈负相关。
要点
- 多数肠道准备质量量表在克罗恩病患者中信度与效度良好。
- FDA BCAS在进镜时的评定者间信度较低(ICC≥0.41)。
- 结肠肠道准备质量与SES-CD评分呈负相关。
核心结论
- 多数现有量表能可靠评估克罗恩病患者的肠道准备质量。
研究设计与样本
- 使用波士顿肠道准备量表、改良波士顿肠道准备量表、哈雷菲尔德清洁量表、美国食品药品监督管理局肠道清洁评估量表(BCAS)及100毫米视觉模拟量表,对40例克罗恩病患者的50段视频评估肠道准备质量。
- 采用克罗恩病简单内镜评分(SES-CD)评估内镜活动度,分别在进镜和退镜时进行评估。
- 信度用组内相关系数(ICC)量化,效度通过混合效应模型分析量表与视觉模拟量表的患者内相关性,肠道准备质量与SES-CD的相关性用斯皮尔曼rho系数评估。
主要发现
- 所有肠道准备质量量表的评定者间和评定者内信度均较高(ICC≥0.61),但FDA BCAS在进镜时的评定者间信度ICC≥0.41。
- 视觉模拟量表评定者间信度较高,评定者内信度几乎完美(ICC≥0.81)。
- 量表效度相关系数超过0.58。
- 结肠肠道准备质量与内镜疾病活动度评分呈负相关。
临床怎么用
- 研究结果支持在临床实践中使用这些量表评估克罗恩病患者的肠道准备质量。
- 研究结果为克罗恩病临床试验中肠道准备质量评分提供了框架。
- 研究结果支持在克罗恩病患者中评估新型肠道准备药物。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The performance of bowel preparation (BP) in patients with Crohn's disease (CD) is unknown. AIMS: To evaluate the operating properties of instruments used to assess BP quality in patients with CD. METHODS: We used the Boston Bowel Preparation Scale, modified Boston Bowel Preparation Scale, Harefield Cleansing Scale, Food and Drug Administration Bowel Cleansing Assessment Scale (BCAS), and a 100-mm visual analogue scale of bowel cleanliness to assess BP quality in 50 videos from 40 patients with CD. We assessed endoscopic activity with the Simple Endoscopic Score for CD (SES-CD). Assessments were on endoscope insertion and withdrawal. Reliability was quantified using the intraclass correlation coefficient (ICC). We assessed validity by within-patient correlation between instruments and the visual analogue scale using mixed-effect models. The correlation between BP quality and SES-SD scores was assessed using Spearman's rho. RESULTS: Inter- and intra-rater reliability for all BP quality instruments was substantial (ICC ≥0.61) except for the Food and Drug Administration BCAS on insertion (inter-rater reliability ICC ≥0.41). The visual analogue scale had substantial inter- and almost perfect (ICC ≥0.81) intra-rater reliability. Correlation coefficients for the validity of the instruments exceeded 0.58. BP quality and endoscopic disease activity scores in the colon were negatively correlated. CONCLUSION: Most existing instruments reliably assess BP quality in patients with CD. These results support the use of these instruments in clinical practice, provide a framework for scoring BP quality in CD clinical trials, and support evaluation of novel BP agents in patients with CD.
引用
- Solitano V, Siegel CA, Korzenik JR, et al. Performance of bowel preparation quality scales in patients with Crohn's disease. Aliment Pharmacol Ther. 2024. PMID: 39129393. doi:10.1111/apt.18210
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。